Synthesis, structure-activity relationships, and in vivo properties of 3,4-dihydro-1H-pyrido[2,3-b]pyrazin-2-ones as corticotropin-releasing factor-1 receptor antagonists

被引：13

作者：

Dzierba, CD ^{[1
]}

Takvorian, AG ^{[1
]}

Rafalski, M ^{[1
]}

Kasireddy-Polam, P ^{[1
]}

Wong, H ^{[1
]}

Molski, TF ^{[1
]}

Zhang, G ^{[1
]}

Li, YW ^{[1
]}

Lelas, S ^{[1
]}

Peng, Y ^{[1
]}

McElroy, JF ^{[1
]}

Zaczek, RC ^{[1
]}

Taub, RA ^{[1
]}

Combs, AP ^{[1
]}

Gilligan, PJ ^{[1
]}

Trainor, GL ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Wallingford, CT 06492 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2004年 / 47卷 / 23期

关键词：

D O I：

10.1021/jm049737f

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Corticotropin releasing factor (CRF) is the primary regulator of the hypothalamus-pituitary-adrenal (HPA) axis, coordinating the endocrine, behavioral, and autonomic responses to stress. It has been postulated that small molecules that can antagonize the binding of CRF, to its receptor may serve as a treatment for anxiety-related and/or affective disorders. Members within a series of 3,4-dihydro-1H-pyrido[2,3-b]pyrazin-2-ones, exemplified by compound 2 (IC50 = 0.70 nM), were found to be very potent antagonists of CRF1. Compound 8w showed high CRF1 receptor binding affinity and was examined further in vivo. The compound was efficacious in a defensive withdrawal model of anxiety in rats and had a long half-life and reasonable oral bioavailability in dog pharmacokinetic studies.

引用

页码：5783 / 5790

页数：8

共 50 条

[11] Synthesis and structure-activity relationship of imidazo[1,2-a]benzimidazoles as corticotropin-releasing factor 1 receptor antagonists
Han, XJ
Pin, SS
Burris, K
Fung, LK
Huang, S
Taber, MT
Zhang, J
Dubowchik, GM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (18) : 4029 - 4032
[12] Synthesis and structure-activity relationships of thieno[2,3-b] pyrroles as antagonists of the GnRH receptor
Arnould, Jean Claude
Delouvrie, Benedicte
Boutron, Pascal
Dossetter, Al G.
Foote, Kevin M.
Hamon, Annie
Hancox, Urs
Harris, Craig S.
Hutton, Mike
Lamorlette, Maryannick
Matusiak, Zbigniew
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (23) : 6448 - 6454
[13] Synthesis, structure-activity relationships, and anxiolytic activity of 7-aryl-6,7-dihydroimidazoimidazole corticotropin-releasing factor 1 receptor antagonists
Han, XJ
Michne, JA
Pin, SS
Burris, KD
Balanda, LA
Fung, LK
Fiedler, T
Browman, KE
Taber, MT
Zhang, J
Dubowchik, GM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (17) : 3870 - 3873
[14] Synthesis and SAR of 8-aza-quinoxalin-2(1H)-one as corticotropin-releasing factor-1 receptor antagonists
Dasgupta, Bireshwar
Dzierba, Carolyn D.
Sielecki, Thais M.
Galka, Amy
Johnson, Tricia L.
Takvorian, Amy G.
Rafalski, Maria
Kasireddy-Polam, Padmaja
Vig, Shikha
Arvanitis, Argyrios G.
Zhang, Ge
Molski, Thaddeus F.
Zaczek, Robert C.
Combs, Andrew P.
Gilligan, Paul J.
Trainor, George
Bronson, Joanne J.
Macor, John E.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
[15] Synthesis and Structure-Activity Relationships of Pyrazolo[1,5-a]pyridine Derivatives: Potent and Orally Active Antagonists of Corticotropin-Releasing Factor 1 Receptor
Takahashi, Yoshinori
Hibi, Shigeki
Hoshino, Yorihisa
Kikuchi, Koichi
Shin, Kogyoku
Murata-Tai, Kaoru
Fujisawa, Masae
Ino, Mitsuhiro
Shibata, Hisashi
Yonaga, Masahiro
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 5255 - 5269
[16] Corticotropin releasing factor-1 receptor antagonists: Synthesis and structure-activity relationships of 1,2,3,7-tetrahydro-6H-purin-6-one and 3,7-dihydro-1H-purine-2,6-dione derivatives.
Hartz, RA
Nanda, KK
Ingalls, CL
Ahuja, VT
Molski, TF
Mattson, GK
Zhang, G
Wong, H
Zaczek, R
Trainor, GL
Gilligan, PJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U62 - U62
[17] Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonists
Guo, ZQ
Tellew, JE
Gross, RS
Dyck, B
Grey, J
Haddach, M
Kiankarimi, M
Lanier, M
Li, BF
Luo, ZY
McCarthy, JR
Moorjani, M
Saunders, J
Sullivan, R
Zhang, XH
Zamani-Kord, S
Grigoriadis, DE
Crowe, PD
Chen, TK
Williams, JP
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (16) : 5104 - 5107
[18] Design, Synthesis, and Structure-Activity Relationships of Novel Pyrazolo[5,1-b]thiazole Derivatives as Potent and Orally Active Corticotropin-Releasing Factor 1 Receptor Antagonists
Takahashi, Yoshinori
Hashizume, Minako
Shin, Kogyoku
Terauchi, Taro
Takeda, Kunitoshi
Hibi, Shigeki
Murata-Tai, Kaoru
Fujisawa, Masae
Shikata, Kodo
Taguchi, Ryota
Ino, Mitsuhiro
Shibata, Hisashi
Yonaga, Masahiro
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (19) : 8450 - 8463
[19] Synthesis and structure-activity relationships of 3H-quinazolin-4-ones and 3H-pyrido[2,3-d]pyrimidin-4-ones as CXCR3 receptor antagonists
Storelli, Stefania
Verzijl, Dennis
Al-Badie, Jawad
Elders, Niels
Bosch, Leontien
Timmerman, Henk
Smit, Martine J.
De Esch, Iwan J. P.
Leurs, Rob
ARCHIV DER PHARMAZIE, 2007, 340 (06) : 281 - 291
[20] Synthesis, structure and biological activity 3-(arylmethyl) aminopyridine-2 (1H) -ones and 1H-pyrido[2,3-b][1,4]oxazin-2(3H)-ones
Kulakov, Ivan, V
Palamarchuk, Irina, V
Shulgau, Zarina T.
Seilkhanov, Tulegen M.
Gatilov, Yuriy, V
Fisyuk, Alexander S.
JOURNAL OF MOLECULAR STRUCTURE, 2018, 1166 : 262 - 269

← 1 2 3 4 5 →